vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Datacentrex, Inc. (DTCX). Click either name above to swap in a different company.

Arcellx, Inc. is the larger business by last-quarter revenue ($8.1M vs $7.0M, roughly 1.2× Datacentrex, Inc.). Datacentrex, Inc. runs the higher net margin — 75.8% vs -766.0%, a 841.8% gap on every dollar of revenue. On growth, Datacentrex, Inc. posted the faster year-over-year revenue change (4463314.1% vs -79.3%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Datacentrex, Inc. is a technology infrastructure service provider offering colocation, managed cloud hosting, and enterprise IT support solutions. It serves small, medium and enterprise clients as well as public sector organizations across North America, focusing on reliable, secure data center operations and customized digital infrastructure services.

ACLX vs DTCX — Head-to-Head

Bigger by revenue
ACLX
ACLX
1.2× larger
ACLX
$8.1M
$7.0M
DTCX
Growing faster (revenue YoY)
DTCX
DTCX
+4463393.4% gap
DTCX
4463314.1%
-79.3%
ACLX
Higher net margin
DTCX
DTCX
841.8% more per $
DTCX
75.8%
-766.0%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
DTCX
DTCX
Revenue
$8.1M
$7.0M
Net Profit
$-62.3M
$5.3M
Gross Margin
Operating Margin
-847.6%
87.2%
Net Margin
-766.0%
75.8%
Revenue YoY
-79.3%
4463314.1%
Net Profit YoY
-765.1%
295.3%
EPS (diluted)
$-1.13
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
DTCX
DTCX
Q4 25
$7.0M
Q1 25
$8.1M
Q4 24
$15.3M
Q3 24
$26.0M
Q2 24
$27.4M
Q1 24
$39.3M
Q4 23
$63.1M
$-374
Q3 23
$15.0M
Net Profit
ACLX
ACLX
DTCX
DTCX
Q4 25
$5.3M
Q1 25
$-62.3M
Q4 24
$-47.1M
Q3 24
$-25.9M
Q2 24
$-27.2M
Q1 24
$-7.2M
Q4 23
$19.8M
$-382.3K
Q3 23
$-39.3M
Operating Margin
ACLX
ACLX
DTCX
DTCX
Q4 25
87.2%
Q1 25
-847.6%
Q4 24
-348.2%
Q3 24
-129.1%
Q2 24
-127.8%
Q1 24
-40.3%
Q4 23
23.8%
99467.1%
Q3 23
-299.9%
Net Margin
ACLX
ACLX
DTCX
DTCX
Q4 25
75.8%
Q1 25
-766.0%
Q4 24
-308.4%
Q3 24
-99.4%
Q2 24
-99.3%
Q1 24
-18.3%
Q4 23
31.4%
102231.3%
Q3 23
-263.0%
EPS (diluted)
ACLX
ACLX
DTCX
DTCX
Q4 25
$0.65
Q1 25
$-1.13
Q4 24
$-0.87
Q3 24
$-0.48
Q2 24
$-0.51
Q1 24
$-0.14
Q4 23
$0.42
$-0.06
Q3 23
$-0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
DTCX
DTCX
Cash + ST InvestmentsLiquidity on hand
$543.3M
$38.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$66.2M
Total Assets
$648.1M
$66.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
DTCX
DTCX
Q4 25
$38.9M
Q1 25
$543.3M
Q4 24
$587.4M
Q3 24
$574.3M
Q2 24
$516.7M
Q1 24
$573.9M
Q4 23
$702.0M
$259.2K
Q3 23
$439.7M
Stockholders' Equity
ACLX
ACLX
DTCX
DTCX
Q4 25
$66.2M
Q1 25
$416.9M
Q4 24
$454.8M
Q3 24
$483.0M
Q2 24
$487.2M
Q1 24
$496.6M
Q4 23
$485.4M
$349.3K
Q3 23
$266.1M
Total Assets
ACLX
ACLX
DTCX
DTCX
Q4 25
$66.8M
Q1 25
$648.1M
Q4 24
$711.3M
Q3 24
$764.9M
Q2 24
$734.3M
Q1 24
$779.7M
Q4 23
$825.1M
$415.2K
Q3 23
$614.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
DTCX
DTCX
Operating Cash FlowLast quarter
$-63.1M
$-1.5M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-786.4%
Capex IntensityCapex / Revenue
9.6%
Cash ConversionOCF / Net Profit
-0.28×
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
DTCX
DTCX
Q4 25
$-1.5M
Q1 25
$-63.1M
Q4 24
$-46.0M
Q3 24
$30.7M
Q2 24
$-36.2M
Q1 24
$-31.9M
Q4 23
$58.2M
$-414.8K
Q3 23
$-10.1M
Free Cash Flow
ACLX
ACLX
DTCX
DTCX
Q4 25
Q1 25
$-63.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
Q4 23
$53.0M
Q3 23
$-18.0M
FCF Margin
ACLX
ACLX
DTCX
DTCX
Q4 25
Q1 25
-786.4%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
Q4 23
83.9%
Q3 23
-120.5%
Capex Intensity
ACLX
ACLX
DTCX
DTCX
Q4 25
Q1 25
9.6%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%
Q4 23
8.4%
Q3 23
53.0%
Cash Conversion
ACLX
ACLX
DTCX
DTCX
Q4 25
-0.28×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
2.94×
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons